Invenomic Capital Management LP Incyte Corp Transaction History
Invenomic Capital Management LP
- $1.75 Billion
- Q3 2024
A detailed history of Invenomic Capital Management LP transactions in Incyte Corp stock. As of the latest transaction made, Invenomic Capital Management LP holds 88,752 shares of INCY stock, worth $6.43 Million. This represents 0.33% of its overall portfolio holdings.
Number of Shares
88,752
Previous 106,237
16.46%
Holding current value
$6.43 Million
Previous $6.44 Million
8.91%
% of portfolio
0.33%
Previous 0.32%
Shares
2 transactions
Others Institutions Holding INCY
# of Institutions
651Shares Held
186MCall Options Held
714KPut Options Held
557K-
Baker Bros. Advisors LP New York, NY30.7MShares$2.23 Billion21.76% of portfolio
-
Black Rock Inc. New York, NY21.4MShares$1.55 Billion0.03% of portfolio
-
Vanguard Group Inc Valley Forge, PA20.4MShares$1.48 Billion0.02% of portfolio
-
Dodge & Cox San Francisco, CA15.3MShares$1.11 Billion0.61% of portfolio
-
State Street Corp Boston, MA10.6MShares$764 Million0.03% of portfolio
About INCYTE CORP
- Ticker INCY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 222,431,008
- Market Cap $16.1B
- Description
- Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...